Leuprolide Acetate Market Research Report, by Application (Prostate Cancer, Precocious, and Uterine Fibroid), by Mode of Administration (Intramuscular, Subcutaneous), by End-User (Hospitals, Clinics, Medical Institutes)- Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.2.1. Increasing prevalence of prostate cancer and uterine fibroids

4.2.2. Upsurge in awareness regarding precocious puberty

4.3. Restraints

4.3.1. Side effects associated with this salt are upset stomach

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL LEUPROLIDE ACETATE MARKET, BY APPLICATION

6.1. Overview

6.2. Prostate Cancer

6.3. Precocious

6.4. Uterine Fibroid

7. GLOBAL LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION

7.1. Overview

7.2. Intramuscular

7.3. Subcutaneous

8. GLOBAL LEUPROLIDE ACETATE MARKET, BY END USER

8.1. Overview

8.2. Hospitals

8.3. Clinics

8.4. Medical Institutes

9. GLOBAL LEUPROLIDE ACETATE MARKET, BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Leuprolide Acetate Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Leuprolide Acetate Market,

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Varian Pharmed

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Pfizer Inc

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Products Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Takeda Pharmaceutical Company Limited

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Products Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Sun Pharmaceutical Industries Ltd

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Products Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Livzon Pharmaceutical Group Co., Ltd

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Products Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. MERCK KGAA

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Products Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Abbott

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Products Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. AbbVie Inc

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Products Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Sanofi

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Products Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Astellas Pharma

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Products Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL LEUPROLIDE ACETATE MARKET, SYNOPSIS, 2019–2032

TABLE 2 GLOBAL LEUPROLIDE ACETATE MARKET, ESTIMATES & FORECAST, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 6 NORTH AMERICA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 7 NORTH AMERICA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 8 NORTH AMERICA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 9 US: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 10 US: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 11 US: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 12 CANADA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 13 CANADA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 14 CANADA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 1 EUROPE: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 2 EUROPE: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 3 EUROPE: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 4 GERMANY: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 5 GERMANY: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 6 GERMANY: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 7 FRANCE: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 8 FRANCE: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 9 FRANCE: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 10 ITALY: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 11 ITALY: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 12 ITALY: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 13 SPAIN: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 14 SPAIN: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 15 SPAIN: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 16 UK: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 17 UK: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 18 UK: LEUPROLIDE ACETATE MARKET, BY END UER, 2019–2032 (USD MILLION)

TABLE 19 REST OF EUROPE: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 20 REST OF EUROPE: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 21 REST OF EUROPE: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 22 ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 23 ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 24 ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 25 JAPAN: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 26 JAPAN: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 27 JAPAN: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 28 CHINA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 29 CHINA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 30 CHINA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 31 INDIA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 32 INDIA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 33 INDIA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 34 AUSTRALIA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 35 AUSTRALIA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 36 AUSTRALIA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 37 SOUTH KOREA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 38 SOUTH KOREA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 39 SOUTH KOREA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 40 REST OF ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 41 REST OF ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 42 REST OF ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 43 REST OF THE WORLD: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 44 REST OF THE WORLD: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 45 REST OF THE WORLD: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 46 MIDDLE EAST: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 47 MIDDLE EAST: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 48 MIDDLE EAST: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 49 AFRICA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 50 AFRICA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 51 AFRICA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 52 LATIN AMERICA: LEUPROLIDE ACETATE MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 53 LATIN AMERICA: LEUPROLIDE ACETATE MARKET, BY MODE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 54 LATIN AMERICA: LEUPROLIDE ACETATE MARKET, BY END USER, 2019–2032 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL LEUPROLIDE ACETATE MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL LEUPROLIDE ACETATE MARKET

FIGURE 4 GLOBAL LEUPROLIDE ACETATE MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 5 GLOBAL LEUPROLIDE ACETATE MARKET, SHARE (%), BY MODE OF ADMINISTRATION, 2022

FIGURE 6 GLOBAL LEUPROLIDE ACETATE MARKET, SHARE (%), BY END USER, 2022

FIGURE 7 GLOBAL LEUPROLIDE ACETATE MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: LEUPROLIDE ACETATE MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: LEUPROLIDE ACETATE MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: LEUPROLIDE ACETATE MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: LEUPROLIDE ACETATE MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL LEUPROLIDE ACETATE MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 VARIAN PHARMED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 VARIAN PHARMED: SWOT ANALYSIS

FIGURE 15 PFIZER INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 PFIZER INC: SWOT ANALYSIS

FIGURE 17 TAKEDA PHARMACEUTICAL COMPANY LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 TAKEDA PHARMACEUTICAL COMPANY LIMITED: SWOT ANALYSIS

FIGURE 19 SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 SUN PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS

FIGURE 21 LIVZON PHARMACEUTICAL GROUP CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 LIVZON PHARMACEUTICAL GROUP CO., LTD.: SWOT ANALYSIS

FIGURE 23 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 MERCK KGAA: SWOT ANALYSIS

FIGURE 25 ABBOTT : FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ABBOTT : SWOT ANALYSIS

FIGURE 27 ABBVIE INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 ABBVIE INC: SWOT ANALYSIS

FIGURE 29 SANOFI : FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 SANOFI : SWOT ANALYSIS

FIGURE 31 ASTELLAS PHARMA : FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 ASTELLAS PHARMA : SWOT ANALYSIS